Column Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Column Capital Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.45K	Buy	+142	New	+$1.32K	﹤0.01%	711
2022 Q2	–	Sell	-199	Closed	-$2K	–	742
2022 Q1	$2K	Hold	199	–	–	﹤0.01%	663
2021 Q4	$2K	Hold	199	–	–	﹤0.01%	678
2021 Q3	$2K	Hold	199	–	–	﹤0.01%	643
2021 Q2	$2K	Hold	199	–	–	﹤0.01%	644
2021 Q1	$2K	Hold	199	–	–	﹤0.01%	633
2020 Q4	$2K	Buy	+199	New	+$1.91K	﹤0.01%	620
2020 Q3	–	Sell	-112	Closed	-$1K	–	858
2020 Q2	$1K	Buy	+112	New	+$1.27K	﹤0.01%	795

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return